美沙拉嗪辅助治疗溃疡性结肠炎的效果研究

Clinical Efficacy of Mesalazine Adjuvant Treatment for Ulcerative Colitis

目的 研究美沙拉嗪辅助治疗溃疡性结肠炎的效果。方法 研究取2014年4月-2015年4月本院溃疡性结肠炎48例,依照治疗方式差异将其分组,24例对照组给予常规治疗;在此基础上,24例研究组应用美沙拉嗪辅助治疗。观察评定疗效,予以组间对比。结果 治疗后,研究组组织学积分较低（P〈0.05）,治疗有效率高（P〈0.05）,不良反应少（P〈0.05）,有差异具有统计学意义。结论 美沙拉嗪辅助治疗溃疡性结肠炎效果佳,治疗可靠、安全。

Objective Mesalazine adjuvant treatment effect of ulcerative colitis is to be studied. Methods Chose 48 patients of ulcerative colitis who are treated in hospital from April 2014 to April 2015 and separate them into groups according to different treatment methods,24 patients in control group are given conventional treatment and another 24 patients in study group are given mesalazine adjuvant treatment,and then observe patients’treatment effects between two groups. Results Patients’histological points in study group is lower（P〈0.05）,treatment efficacy is higher（P〈0.05）and side effects are fewer（P〈0.05）,there is a differential between two groups. Conclusion Mesalazine adjuvant treatment is quite effective in treatment of ulcerative colitis thus,such a reliable and safe medication treatment.